2001

30 July 2001. Related: Treatment access.

Yale economist introduces proposal to settle debate between pharmaceutical companies and developing nations

30 July 2001. Related: Treatment access.

Kenyan lawmakers approve bill to suspend drug patent rights and improve cheaper drug access

30 July 2001. Related: Treatment access.

African advocacy groups call for dismissal of USAID director Natsios after ‘racist comments’

30 July 2001. Related: Other news.

Thai officials call for cancellation of AIDS ‘miracle cure’ distribution amid controversy

30 July 2001. Related: Cure-related research, Other news.

South African government issues first draft of legislation allowing importation of discounted pharmaceuticals

30 July 2001. Related: Treatment access.

International aid group to begin administering AIDS drugs to small group of poor South Africans

30 July 2001. Related: Treatment access.

Britain to Donate £75 million to global AIDS fund

30 July 2001. Related: Treatment access.

Uganda to offer free HIV drugs to pregnant women to prevent vertical HIV transmission

30 July 2001. Related: Treatment access, Pregnancy.

Immunologic profile of HIV-positive patients during viral remission and relapse on antiretroviral therapy

30 July 2001. Related: Basic science and immunology.

T-20: will long-term use weaken the immune system’s ability to fight HIV?

30 July 2001. Related: Antiretrovirals.

The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons

30 July 2001. Related: Antiretrovirals.

Ritonavir approved in Europe as pharmacokinetic enhancer for use with other antiretrovirals

30 July 2001. Related: Antiretrovirals.

A warning about milk thistle (silymarin) and drug interactions

30 July 2001. Related: PK and drug interactions.

Breastfeeding may increase maternal mortality among HIV-positive women, study shows

30 July 2001. Related: Pregnancy.

Prevalence of the T215Y mutation in HIV type 1-infected pregnant women in a New York cohort, 1995-1999

30 July 2001. Related: Pregnancy, Drug resistance.

HIV-positive women at high risk for pre-cancerous anal lesions

30 July 2001. Related: Women's health, Cancer and HIV.

Sexual dysfunction associated with protease inhibitor containing HAART

30 July 2001. Related: Side effects.

Nevirapine use linked to icteric hepatitis in some HIV-positive patients

30 July 2001. Related: Side effects.

Tattoos flare up from HAART

30 July 2001. Related: Side effects.

Impaired replication of protease inhibitor-resistant HIV-1 in human thymus

30 July 2001. Related: Basic science and immunology, Drug resistance.

Basis of HIV resistance suggests new vaccine strategy

30 July 2001. Related: Basic science and immunology, Vaccines and microbicides.

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS

30 July 2001. Related: Basic science and immunology.

Canada Reverses ban on entry of HIV-positive immigrants

30 July 2001. Related: Other news.

Bristol-Myers Squibb agrees to purchase DuPont’s drug business

30 July 2001. Related: Other news.

NEJM commemorates 20 years of AIDS with early-release retrospective

30 July 2001. Related: Other news.

New York’s Beth Israel Hospital making post-exposure HIV treatment available to general public

30 July 2001. Related: Other news.

Strategies to cut risky sexual behaviour may do more harm than good

30 July 2001. Related: On the web.

ABC of AIDS – HIV infection and AIDS in the developing world

30 July 2001. Related: On the web.

Treatment of hyperlipidemia in HIV-positive patients

30 July 2001. Related: Side effects, Lipodystrophy and metabolic complications.

Current review on hepatitis C virus in HIV/HCV coinfection

30 July 2001. Related: On the web.

ABC of AIDS – antiretroviral drugs

30 July 2001. Related: On the web.

Volume 2 Number 6 July 2001 PDF

1 July 2001. Related: PDFs.

4th International Conference on Nutrition and HIV Infection and the 2nd European Workshop on Lipodystrophy, April 19-21, 2001, Cannes, France

30 June 2001. Related: Conference reports.

4th International Conference on Nutrition and HIV Infection and the 2nd European Workshop on Lipodystrophy – pt 2

30 June 2001. Related: Conference reports.

A new women’s research agenda starts to see the light of day

30 June 2001. Related: Women's health.

Tenofovir: Gilead applies for approval, expanded access relaxed

30 June 2001. Related: Antiretrovirals.

Cipla announces plan to manufacture 3-in-1 HIV pil

30 June 2001. Related: Treatment access.

Huge mining firm to provide African employees with AIDS medications

30 June 2001. Related: Treatment access.

South African Department of health has not killed possibility of AIDS drug provision, letter says

30 June 2001. Related: Treatment access.

Government, pricing not the only problems

30 June 2001. Related: Treatment access.

South Africa AIDS drug settlement may not signify immediate influx of drugs

30 June 2001. Related: Treatment access.

AIDS crisis has Sspurred public relations challenges for pharmaceutical industry, Wall Street Journal reports

30 June 2001. Related: Treatment access.

Incidence of invasive cervical cancer in a cohort of HIV-infected women before and after the introduction of HAART

30 June 2001. Related: Women's health, Cancer and HIV.

CD4+ counts predictive of musculoskeletal manifestations of HIV infection

30 June 2001. Related: Coinfections and complications.

Effect of highly active antiretroviral therapy on frequency of oral warts

30 June 2001. Related: Coinfections and complications.